These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9648476)

  • 1. [Vitamin K2].
    Shiraki M
    Nihon Rinsho; 1998 Jun; 56(6):1525-30. PubMed ID: 9648476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.
    Shiraki M; Shiraki Y; Aoki C; Miura M
    J Bone Miner Res; 2000 Mar; 15(3):515-21. PubMed ID: 10750566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin K2 (menatetrenone) and bone quality].
    Iinuma N
    Clin Calcium; 2005 Jun; 15(6):1034-9. PubMed ID: 15930719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-fracture efficacy of vitamin K].
    Iwamoto J
    Clin Calcium; 2009 Dec; 19(12):1805-14. PubMed ID: 19949272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Active vitamin D and vitamin K as therapeutic agents for osteoporosis].
    Katagiri H
    Nihon Rinsho; 2006 Sep; 64(9):1639-43. PubMed ID: 16972672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women.
    Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M
    Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Clin Endocrinol (Oxf); 2004 May; 60(5):568-75. PubMed ID: 15104559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K2 treatment for postmenopausal osteoporosis in Indonesia.
    Purwosunu Y; Muharram ; Rachman IA; Reksoprodjo S; Sekizawa A
    J Obstet Gynaecol Res; 2006 Apr; 32(2):230-4. PubMed ID: 16594930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vitamin K and osteoporosis].
    Luo LZ; Xu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):346-9. PubMed ID: 12905754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
    Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin K2: a novel therapy for osteoporosis.
    Prabhoo R; Prabhoo TR
    J Indian Med Assoc; 2010 Apr; 108(4):253-4, 256-8. PubMed ID: 21114195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
    McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
    J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
    Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
    J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
    Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
    J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of vitamin K2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats.
    Iwamoto J; Matsumoto H; Takeda T; Sato Y; Yeh JK
    Calcif Tissue Int; 2010 Sep; 87(3):254-62. PubMed ID: 20556371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.
    Adachi JD; Saag KG; Delmas PD; Liberman UA; Emkey RD; Seeman E; Lane NE; Kaufman JM; Poubelle PE; Hawkins F; Correa-Rotter R; Menkes CJ; Rodriguez-Portales JA; Schnitzer TJ; Block JA; Wing J; McIlwain HH; Westhovens R; Brown J; Melo-Gomes JA; Gruber BL; Yanover MJ; Leite MO; Siminoski KG; Nevitt MC; Sharp JT; Malice MP; Dumortier T; Czachur M; Carofano W; Daifotis A
    Arthritis Rheum; 2001 Jan; 44(1):202-11. PubMed ID: 11212161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alendronate for the treatment of osteoporosis in men.
    Orwoll E; Ettinger M; Weiss S; Miller P; Kendler D; Graham J; Adami S; Weber K; Lorenc R; Pietschmann P; Vandormael K; Lombardi A
    N Engl J Med; 2000 Aug; 343(9):604-10. PubMed ID: 10979796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.